The Royal Blackburn Teaching Hospital is an acute District General Hospital in Blackburn, Lancashire operated by the East Lancashire Hospitals NHS Trust.

During the past decade, East Lancashire Hospitals NHS Trust conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Lancashire Hospitals NHS Trust" #1 sponsor was "Lancaster University" with 2 trials, followed by "AVEO Pharmaceuticals, Inc." with 1 trials sponsored, "The Leeds Teaching Hospitals NHS Trust" with 1 trials sponsored, "University College, London" with 1 trials sponsored and "University of British Columbia" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Lancashire Hospitals NHS Trust" #1 collaborator was "East Lancashire Hospitals NHS Trust" with 2 trials as a collaborator, "Aneurin Bevan University Health Board" with 1 trials as a collaborator, "Association of Surgeons of Great Britain and Ireland" with 1 trials as a collaborator, "Barnsley Hospital NHS Foundation Trust" with 1 trials as a collaborator and "British Society for Gynaecological Endoscopy" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "East Lancashire Hospitals NHS Trust" are "Bladder Cancer" (1 trials), "Carcinoma, Renal Cell" (1 trials), "Cognitive Impairment" (1 trials), "Diarrhea" (1 trials) and "Fatigue" (1 trials). Many other conditions were trialed in "East Lancashire Hospitals NHS Trust" in a lesser frequency.

Most popular intervention types in "East Lancashire Hospitals NHS Trust" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intervention is blood pressure management approach" (1 trials), "Intervention is blood pressure management approach." (1 trials), "Sorafenib" (1 trials) and "tivozanib hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "East Lancashire Hospitals NHS Trust" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "East Lancashire Hospitals NHS Trust". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in East Lancashire Hospitals NHS Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in East Lancashire Hospitals NHS Trust, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".